Alan S. Roemer - 21 Nov 2023 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/John Rudy, attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
21 Nov 2023
Net transactions value
-$16,045
Form type
4
Filing time
22 Nov 2023, 17:18:01 UTC
Previous filing
07 Jul 2023
Next filing
15 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Sale $8,287 -3,833 -49% $2.16 3,992 21 Nov 2023 Direct F1
transaction NEXI Common Stock Sale $7,758 -3,992 -100% $1.94 0 22 Nov 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.39 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.
F2 The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.05 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.